Posted On: 11/29/2016 4:34:14 PM
Post# of 22839
$ARWR -66% on bad news.
Arrowhead to focus resources on subcutaneous and extra-hepatic RNAi therapeutics; three clinical-stage drug candidates axed; 30% of workforce cut; shares down 2% after hours
http://seekingalpha.com/news/3227473-arrowhea...ical-stage
Arrowhead to focus resources on subcutaneous and extra-hepatic RNAi therapeutics; three clinical-stage drug candidates axed; 30% of workforce cut; shares down 2% after hours
http://seekingalpha.com/news/3227473-arrowhea...ical-stage
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
Scroll down for more posts ▼
